Cargando…

Risk of colorectal cancer for carriers of a germline mutation in POLE or POLD1

BACKGROUND: Germline mutations in the exonuclease domains of the POLE and POLD1 genes are associated with an as yet unquantified increased risk of colorectal cancer (CRC). METHODS: We identified families with POLE or POLD1 variants by searching PubMed for relevant studies prior to October 2016 and b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Buchanan, Daniel D., Stewart, Jenna R., Clendenning, Mark, Rosty, Christophe, Mahmood, Khalid, Pope, Bernard J., Jenkins, Mark A., Hopper, John L., Southey, Melissa C., Macrae, Finlay A., Winship, Ingrid M., Win, Aung Ko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943186/ https://www.ncbi.nlm.nih.gov/pubmed/29120461 http://dx.doi.org/10.1038/gim.2017.185

Ejemplares similares

Genetic variants within the hTERT gene and the risk of colorectal cancer in Lynch syndrome
por: Win, Aung Ko, et al.
Publicado: (2015)

Recommendations for the classification of germline variants in the exonuclease domain of POLE and POLD1
por: Mur, Pilar, et al.
Publicado: (2023)

DNA Methylation Signatures and the Contribution of Age-Associated Methylomic Drift to Carcinogenesis in Early-Onset Colorectal Cancer
por: Joo, Jihoon E., et al.
Publicado: (2021)

Germline Mutations in the Polyposis-Associated Genes BMPR1A, SMAD4, PTEN, MUTYH and GREM1 Are Not Common in Individuals with Serrated Polyposis Syndrome
por: Clendenning, Mark, et al.
Publicado: (2013)

Body Mass Index, sex, non-steroidal anti-inflammatory drug medications, smoking and alcohol are differentially associated with World Health Organisation criteria and colorectal cancer risk in people with Serrated Polyposis Syndrome: an Australian case-control study
por: Anthony, Emma, et al.
Publicado: (2022)

Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort
por: Rosty, Christophe, et al.
Publicado: (2016)

Germline mutations in the proof-reading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas
por: Palles, Claire, et al.
Publicado: (2012)

Role of POLE and POLD1 in familial cancer
por: Mur, Pilar, et al.
Publicado: (2020)

POLE/POLD1 mutation and tumor immunotherapy
por: Ma, Xiaoting, et al.
Publicado: (2022)

Germline POLE and POLD1 proofreading domain mutations in endometrial carcinoma from Middle Eastern region
por: Siraj, Abdul K., et al.
Publicado: (2019)

Clinical problems of colorectal cancer and endometrial cancer cases with unknown cause of tumor mismatch repair deficiency (suspected Lynch syndrome)
por: Buchanan, Daniel D, et al.
Publicado: (2014)

POLE and POLD1 germline exonuclease domain pathogenic variants, a rare event in colorectal cancer from the Middle East
por: Siraj, Abdul K., et al.
Publicado: (2020)

A mosaic pathogenic variant in MSH6 causes MSH6-deficient colorectal and endometrial cancer in a patient classified as suspected Lynch syndrome: a case report
por: Walker, Romy, et al.
Publicado: (2023)

Rare germline variants in POLE and POLD1 encoding the catalytic subunits of DNA polymerases ε and δ in glioma families
por: Weber, Christine A. M., et al.
Publicado: (2023)

Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome
por: Dashti, S. Ghazaleh, et al.
Publicado: (2019)

Metachronous colorectal cancer risk for mismatch repair gene mutation carriers – the advantage of more extensive surgery
por: Parry, Susan, et al.
Publicado: (2011)

Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers
por: Joo, Jihoon E., et al.
Publicado: (2023)

PIK3CA Activating Mutation in Colorectal Carcinoma: Associations with Molecular Features and Survival
por: Rosty, Christophe, et al.
Publicado: (2013)

Detection of Allelic Variants of The POLE and POLD1 Genes in Colorectal Cancer Patients
por: Pätzold, LA, et al.
Publicado: (2017)

POLE and POLD1 pathogenic variants in the proofreading domain in papillary thyroid cancer
por: Siraj, Abdul K, et al.
Publicado: (2020)

Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
por: Zhu, Mingyu, et al.
Publicado: (2022)

Tumor mutational signatures in sebaceous skin lesions from individuals with Lynch syndrome
por: Georgeson, Peter, et al.
Publicado: (2019)

Hyperplastic Polyposis and the smoking paradox in females
por: Buchanan, Daniel D, et al.
Publicado: (2011)

Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes
por: Win, A K, et al.
Publicado: (2011)

Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps
por: Elsayed, Fadwa A., et al.
Publicado: (2019)

POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer
por: Esteban-Jurado, Clara, et al.
Publicado: (2017)

The relationship between the BRAF p.V600E mutation and a family history of CRC in the early-onset CRC cases from the Australasian Colon Cancer Family Study
por: Buchanan, DD, et al.
Publicado: (2012)

Germline miRNA DNA variants and the risk of colorectal cancer by subtype
por: Lindor, Noralane M., et al.
Publicado: (2016)

Roles of human POLD1 and POLD3 in genome stability
por: Tumini, Emanuela, et al.
Publicado: (2016)

Combined mismatch repair and POLE/POLD1 defects explain unresolved suspected Lynch syndrome cancers
por: Jansen, Anne ML, et al.
Publicado: (2016)

POLE/POLD1 mutation in non‐exonuclease domain matters for predicting efficacy of immune‐checkpoint‐inhibitor therapy
por: Chen, Yan‐Xing, et al.
Publicado: (2021)

Unraveling the impact of a germline heterozygous POLD1 frameshift variant in serrated polyposis syndrome
por: Bonjoch, Laia, et al.
Publicado: (2023)

Family history–based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios
por: Dillon, Mary, et al.
Publicado: (2018)

Integrating POLE / POLD1 mutated for immunotherapy treatment planning of advanced stage non‐small cell lung cancer
por: Zheng, Shuhua, et al.
Publicado: (2023)

Is RNASEL:p.Glu265* a modifier of early-onset breast cancer risk for carriers of high-risk mutations?
por: Nguyen-Dumont, Tú, et al.
Publicado: (2018)

Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population
por: Yao, Jianfei, et al.
Publicado: (2019)

A study of cancer risks in relatives of patients with serrated polyposis
por: Win, AK, et al.
Publicado: (2012)

POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance
por: Bellido, Fernando, et al.
Publicado: (2016)

Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal Cancer
por: Jenkins, Mark A, et al.
Publicado: (2021)

DNA Mismatch Repair Gene Variant Classification: Evaluating the Utility of Somatic Mutations and Mismatch Repair Deficient Colonic Crypts and Endometrial Glands
por: Walker, Romy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_84j1vbqn09ll25rjliuv35v3lp